相关实验视频

Updated: Jun 3, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

增长差异化因子15的决定因素周围动脉疾病的门诊患者的血水平

Emma Skau^1,2, Philippe Wagner¹, Jerzy Leppert¹

¹Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Upsala journal of medical sciences

|January 9, 2025

概括

周围动脉疾病 (PAD) 患者的生长差异化因子15 (GDF-15) 水平与传统的心血管风险因素如糖尿病和LDL胆固醇有关,而不是直接与动脉样硬化负担有关. 进一步的研究应该探索动脉样硬化中的代谢过程,以了解GDF-15的作用.

科学领域:

心血管疾病研究研究
生物标记分析生物标记分析
代谢综合征是代谢综合征的一种.

背景情况:

增长分化因子15 (GDF-15) 是心血管疾病中已知的预后生物标志物.
了解GDF-15的临床决定因素对于患有外围动脉疾病 (PAD) 的患者至关重要.

研究的目的:

调查GDF-15水平与传统心血管风险因素之间的关联.
检查GDF-15与动脉样硬化负担指标之间的关系.
评估GDF-15水平与心脏几何学和PAD门诊患者的功能障碍有关.

主要方法:

这是一项探索性横截面研究,涉及439名患有PAD的门诊患者.
测量GDF-15的血水平与病史,生化数据,心声学,脚-手臂指数 (ABI) 和大脑动脉超声学 (内心介质厚度[IMT],大脑动脉狭窄) 一起进行.
用单变量和多变量线性回归模型来评估GDF-15与决定因素之间的关联.

主要成果:

多变量分析揭示了GDF-15与糖尿病 (β=0.37),LDL胆固醇 (β=-0.22) 和体力活动 (β=-0.16) 之间的独立关联.
糖尿病,LDL胆固醇和体力活动显示出与GDF-15水平的最强的独立关系.
没有发现GDF-15与心脏几何/功能,ABI,IMT或动脉狭窄之间存在显著的独立关联.

结论:

在PAD患者中,循环GDF-15与传统的心血管风险因素更强烈相关,而不是对动脉样硬化负担或心脏功能障碍的直接测量.
未来的研究应该专注于动脉样硬化疾病中的代谢过程,以阐明GDF-15在PAD结果中的病理生理学作用和临床意义.

关键词:

动脉样硬化是一种动脉样硬化.这是GDF-15的GDF-15.生物标志物生物标志物糖尿病糖尿病患者糖尿病患者周围动脉疾病周围动脉疾病

更多相关视频

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Decellularization and Recellularization Methodology for Human Saphenous Veins

Decellularization and Recellularization Methodology for Human Saphenous Veins

Published on: July 27, 2018

相关概念视频

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...